We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Chip Identifies Toxicity as a Biological Quality

By LabMedica International staff writers
Posted on 30 Jul 2012
Image: Scientists have combined biology and engineering to produce a biosensor device called the "Dip Chip," which detects toxicity quickly and accurately, generating low false positive and false negative readings (Photo courtesy of Tel Aviv University).
Image: Scientists have combined biology and engineering to produce a biosensor device called the "Dip Chip," which detects toxicity quickly and accurately, generating low false positive and false negative readings (Photo courtesy of Tel Aviv University).
A biosensor detects toxicity quickly and accurately, generating low false positive and false negative readings.

Called the Dip Chip, the device contains microbes designed to exhibit a biological reaction to toxic chemicals, emulating the biological responses of humans or animals.

Invented by Prof. Yosi Shacham-Diamand, vice dean of Tel Aviv University's Faculty of Engineering (Ramat Aviv, Israel) together with Prof. Shimshon Belkin of the Institute of Life Sciences at the Hebrew University of Jerusalem (Givat Ram, Jerusalem, Israel), the device contains microbes designed to exhibit a biological reaction to toxic chemicals, emulating the biological responses of humans or animals. The biological reaction is converted into an electronic signal that can be read by the user.

"In my lab, we developed a method for communicating with the microbes, converting this biological response to electrical signals," Prof. Shacham-Diamand explained. The device, which looks like a dipstick, immobilizes these specially produced microbes next to the sensing electrodes. Once the microbes come into contact with a questionable substance they produce a chemical signal that is converted to an electrical current by a device that can interpret the signals, producing a binary toxic or not toxic diagnosis.

The new chips are based on genetically modified microbes developed in Prof. Belkin's lab. When the modified microbes are exposed to toxic or poisonous materials, they produce a measurable biochemical reaction, which is converted into to electrical signals.

The Dip Chip is designed to alert the user to overall toxicity. Because the chip measures general toxicity, it will pick up on any and all toxic materials -- even those that have not been discovered or invented. Beyond their ability to find toxic chemicals in the field, these chips can also be put to use in the cosmetics or pharmaceutical industries, said Prof. Shacham-Diamand.

Related Links:
Tel Aviv University's Faculty of Engineering
Institute of Life Sciences at the Hebrew University of Jerusalem


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated MALDI-TOF MS System
EXS 3000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more